Votis Subdermal Imaging Technologies, Ltd. is a start-up that has developed an innovative device capable of screening and diagnosing the severity of lower limb vascular diseases usually caused by diabetes, including Peripheral Artery Disease (PAD) and consequent Chronic limb- threatening ischemia (CLTI). The team includes engineers experienced in developing medical devices, and its advisors include clinicians and professors ranging from podiatrists to vascular surgeons, and consultants of international standing who share decades of experience in vascular medical devices. The technology, originally developed and patented by Columbia University, is exclusively licensed to Votis worldwide for all medical imaging purposes.